Bupa agrees two-year treatment deal with Mayo Clinic

Mayo Clinic Healthcare, the London facility of healthcare provider Mayo Clinic, has agreed a two-year contract with Bupa to deliver care for the health insurer’s UK customers.

This includes consultations, diagnostics, endoscopy, MRI and CT services at the clinic in Portland Place, London.

Mayo Clinic Healthcare also provides a secondary clinical review for Bupa customers who may benefit from CAR-T cell therapy. The treatment uses patients’ own immune system cells to treat a small number of advanced cancers.

Commenting on the agreement, Dr Anton Decker, gastroenterologist and president of Mayo Clinic International, said: “The relationship with Bupa is an important part of the evolution and growth of Mayo Clinic Healthcare.

“We are privileged to partner with Bupa and it affirms our commitment to care for patients in comprehensive and collaborative ways.”

Alex Perry, CEO of Bupa Insurance, added: “Mayo Clinic Healthcare’s reputation speaks for itself, so its new London clinic is a great addition to the portfolio of hospitals and clinics where our customers can receive treatment and care.”

 

Exit mobile version